carmen raventos-suarez ph.d. bristol-myers squibb...carmen raventos-suarez ph.d....

50
Carmen Raventos-Suarez Ph.D. [email protected] (609-252-6492) Bristol-Myers Squibb

Upload: others

Post on 22-May-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Carmen Raventos-Suarez [email protected]

(609-252-6492)

Bristol-Myers Squibb

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

Page 2: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

When We Study Cells

FACS Answers presented on this workshopProliferation: What When and HowArrest: Why “When” is a key featureApoptosis: Dealing with the kinetics of a

disappearing population

At the microscope we can visualize many structures inside the cells

Photographs from Molecular Probes web site

Page 3: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

ProliferationWhat?

A cycling phenomena regulated by check point controlsDNA duplication followed by segregation into two new entities

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

Page 4: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Proliferation

• Basic science research– signal transduction evaluation

• Pharmaceutical industry– biochemical to cellular assays

• Clinical follow up– cancer therapeutic efficiencies– inflammatory cascades identification– immune activation responses

When do you measure it?

Page 5: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Profile Components

G0/G1

S G2/M

DNA (area)

Cell Questsoftware

Sub-G1 Tetraploid

A picture of DNA Synthesis

Page 6: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Profiles:A Personal Signature of Cells

DNA histograms gives a first hint about cells proliferation potential

DNA-PI

Slow growth Fast growth

Page 7: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Proliferation Features

What does “Cell Cycle Profiles” really mean?

0

200

400

600

800

1000

FL2-A: PI Sparse

Logaritmic

Confluent

A2780WT

0

200

400

600

800

1000

FL2-A: PI

A2780DDP

Confluent

Logaritmic

Sparse

FlowJo Software

Page 8: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• DNA content and population distributions

G150%

S30%

G2/M 20%

24h Cell cycle 12hrs 7.2hrs 4.8hrs

G140%

S38%

G2/M 22%

24h

24h

new cycle

18h Cell cycle 7.2 hrs 6.8 hrs 3.9hrs 6h additional hours of growth

Number of cells =100

Number of cells =125

Cell Cycle Times and Numbers

Page 9: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

When A Cell Divides

Modified from Cell Signaling Web site

G1

S

G2/M

Addressing cells one at a time

Page 10: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Getting The Components Right

The Question of Doublet Discrimination

Alternatively Area vs. Height is also a way to discriminate doublets and higher clumps

FlowJo Software

Page 11: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Profile of Single Cells

Gated vs. non gated populations Previous plots

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

# C

ells

single cells

%G1

%S

%G2

%<G1

%>G2

28.9

22.6

38.2

10.6

-0.47

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

# C

ells

Ungated

%G1

%S

%G2

%<G1

%>G2

26.3

17.3

30.1

18

9.24

0 200 400 600 800 1000FL2-A: FL2-Area

0

500

1000

1500

# C

ells

Single cells

%G1

%S

%G2

%<G1

%>G2

75.5

14.9

3.84

4.05

0.82

0 200 400 600 800 1000FL2-A: FL2-Area

0

500

1000

1500

# C

ells

Ungated

%G1

%S

%G2

%<G1

%>G2

64.5

15.1

7.35

7.14

4.58

0 200 400 600 800 1000FL3-A: DNA-7AAD

0

100

200

300

400

# C

ells

single cells

%G1

%S

%G2

%<G1

%>G2

21.8

48.9

25.4

0.8

3.49

0 200 400 600 800 1000FL3-A: DNA-7AAD

0

100

200

300

400

# C

ells

Ungated

%G1

%S

%G2

%<G1

%>G2

12.4

26.5

23.8

2.05

35.9

FlowJo Software

Page 12: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Nuclei vs. Whole Cells

Nuclei

•Ploidy paraffin blocks

•Apoptosis problems

•Nuclear localization

Whole cells

•Ploidy fresh samples

•Apoptosis efficiency

•Cytoplasmic markers.

What is better?

Page 13: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Software Packages

• Multicycle• Modfit• FlowJo All are packages that contain algorithms with

different restrictions bound to their calculations.Unfortunately, no algorithms are consistently reliable in fitting all thedistributions you may encounter. You may have to experiment with differentoptions and constraints in finding your best results. (copied FlowJo quote)

Getting Numbers to Fit Your Data

Page 14: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Getting To See The NumbersWatson Pragmatic vs. Dean Jett Fox in FlowJo software

Alice Givan previously showed the Mod Fit variations on their selective options

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

# C

ells

0 200 400 600 800 1000FL2-A: DNA-PI

0

100

200

300

400

# C

ells

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

800

1000

# C

ells

single

%G1

%S

%G2

47.7

32.2

14.5

single

%G1

%S

%G2

18.4

35.1

36.8

single

%G1

%S

%G2

22.8

31.5

35.7

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

# C

ells

0 200 400 600 800 1000FL2-A: DNA-PI

0

100

200

300

400

# C

ells

0 200 400 600 800 1000FL2-A: DNA-PI

0

200

400

600

800

1000

# C

ells

single

%G1

%S

%G2

48.8

26.2

20.6

single

%G1

%S

%G2

22.3

28.3

40.5

single

%G1

%S

%G2

25.1

29.8

37.5

Page 15: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Precautions-Tissue Culture Monolayers

• Learn the metabonomics of your cells– Doubling times, density optimization

• Cell Culture Stocks Maintenance– Rigid protocol for split times/avoid overgrowth

• Protocol for Experimental Tests– Standardized number of cells & scheduling– Efficiently trypsinize to a unicellular suspension

Page 16: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• Adding a second marker to your cells– Cell identification markers (CD’s or signal transduction probes)– DNA doubling features, BrdU incorporation

• Adding a third or more markers to your cells– When preset configuration is fixed in your instrument

Search for probes that allow to you the best combinations on added color– When you are able to set up your own configuration

First pick up different lasers then change your dichroics and band filters

Beyond DNA Quantitative Analysis

How to add more significance to your data?

Page 17: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Proliferation and BrdU

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

0 200 400 600 800 1000FL2-A

1

10

100

1000

10000

FL1-H

K562

A2780S

30min pulse 5hrs release 8hrs release

FlowJosoftware

S phase and Doubling Times

Page 18: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Calculating the Numbers

From: Cell Cycle Kinetics Estimated by Analysis of Bromodeoxyuridine Incorporation. Terry N.H.A., and White A. Methods in cell Biology 63:355-374 (1994)

Getting the mathematics to work for you

Page 19: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Overall messages

• When to do DNA?– Maybe every time you address cells

• Watch out! Single cells exclusively– Cell preparation. Avoid clumping

• How to address specific questions?– Cell culture conditions. Use tight protocols– Most appropriate software. Up to you

Page 20: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

References• Solid Tumor dissociation and storage (nuclei)

– Cerra.R., Zarbo R.J., and Crissman. JD.,1990 Dissociation of cells from Solid Tumors. Methods inCell biology 33: 1-12

– Vindelov.L.L.,Cristensen.IJ. An integrated set of methods for routine flow cytometry DNAAnalysis. 1990. Methods in Cell biology 33: 127-137

• Cell Lines (whole cells)– Pozarowwski.P., Darzynkiewiwicz.Z. Analysis of Cell Cycle by Flow Cytometry. 2004. Methods

Mol Biol 281:301-311.– Traganos.F.,Juan.G.,Darzynkiewiwicz.Z. Cell Cycle Analysis of Drug treated Cells 2001. Methods

Mol Biol 95:229-240.

• Overall– Rabinovitch.P.S. Practical considerations for DNA Content and Cell Cycle Analysis in Clinical

Flow Cytometry. Principles and applications. Williams and Wilkins-1993– Pham.NA., Jaccobberger.JW.,Schimmer.A.D.,Cao.P.,Gronda.M.,Hedley.D.W. 2004. The dietary

isothiocyanate sulforaphane targets pathways of apoptosis,cell cycle arrest, and oxidative stress inhuman pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficientmice. Mol.Cancer.Ther.3:1239-1248

– Bagwell.B. et al. 2004. Optimizing Flow Cytometric DNA ploidy and S phase Fraction asnNegative prosnostic Markers for Node-Negative Breast Cancer Specimens Cytometry 46:121-135

Page 21: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Proliferation Disturbances

Arrest

A Way to Cope with Stress

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

Page 22: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• A slowdown in cell cycle progression?• A reversible or irreversible block in one phase of

the cycle?• An induced effect of stress or toxic insult?• A response of the cell genetic makeup?• All of the above?

ARRESTWhat is it?

Page 23: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

The Meaning of Cell Cycle Arrest

Control Campthothecin Cisplatin Paclitaxel

Cell growth arrest induced by stress or chemical compounds are efficiently identified when cells are growing at their optimal logarithmic rates and inducers are at an equilibrium concentration where cells are halted to activate repair mechanisms or apoptosis

Cell Questsoftware

How Do You Identify Specific Growth Arrest?

Page 24: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

CellQuest software

Identification of Arrest

Laidlaw, J., Raventos-Suarez,C., Fairchild, C.R., Peterson, R.W., and Menendez, A.T. Taxol and taxotere have similar potency in cytotoxicity assays, cell selectivity, bcl-2 phosphorylation, G2/M arrest and induction of apoptosis.91st Annual meeting of the AACR. San Francisco, April 1-5. 2000.

Titrations

Paclitaxel a model drug for G2/M arrest

Page 25: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

FlowJo Software

LnCaPCamptothecin

0200

400600

8001000FL2-A: DNA-PI

Control none

1nM

3nM

10nM

30nM

100nM

0200

400600

8001000FL2-A: DNA-PI

Control none

1nM

3nM

10nM

30nM

100nM

A2780Camptothecin

More titrations

Camptothecin a Model drug for S arrest?

Identification of Arrest

Page 26: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• Preliminary Requirements– Cytotoxic tests provide the best tool to identify dosage

• Cell Cycle Titration Curves– Cell cycle profiles need to be address one cycle of

growth at a time– Preliminary titration curves done at a 24h time point

provide good hints of activity

How to Evaluate a Compound

Page 27: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Arrest As An Assay

• The Story of BMS-250497– BMS-250497 is the first non camptothecin compound

described to be specific for Topoisomerase I inhibition.– Because of the side effects of camptothecin another

efficient compound with this kind of activity have beenactively pursued by the pharmaceutical industry

– Biochemical assays required confirmation at the cellularlevel to reinforce the value of this compound as a candidatefor the clinic

Mechanism of Action

Page 28: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Results on BMS-250749

Control 0.1x 1x 5x 10x 20x IC50

• Flow cytometryanalysis of A2780cells with wt p53

• Effects ofBMS-250749 andcamptothecin

CamptothecinIC50 = 10 nM

BMS-250749IC50 = 3 nM

CellQuest software

-Raventos-Suarez,C., Class. K., Buczek,J,L.,Balasubramanian,N., Long, B., and Menendez, A,T. 2001 Topoisomerase I is the Target Responsible for Cytotoxicity of BMS-250749: Confirmation by Flow Cytometry 92th Annual Meeting, New Orleans March 24-28; Proc. AACR 2001 42:103 Abs 562-Raventos-Suarez,C., Class, K., Wild, R., Menendez, A., Long, B. 004 IN VITRO Specificity Profiling of Cellular Topoisomerase Activities Using FACS Analyses.2ISAC XXII International Congress on Analytical Cytology. May22-27 2004 Montpellier, France. Cytometry 58A: p115 Abst# 96207

Page 29: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

In Arrest Profiles

488nm laser 633nM laser 488nm laser 633nM laser

HCT116 HCT116 (VM46)

DNA Cell Cycle Profiles

HCT116 HCT116(VM46)

Cyclin B1 Profiles

Comparison between PI and ToPro3 Blue= 488nm Red=633nm

DNA Cyclin B1 Cyclin E Cyclin A

0 200 400 600 800 1000FL4-A: FL4 A

0

200

400

600

800

1000

FL

2-H

: F

L2

-He

igh

t

0 200 400 600 800 1000FL4-A: FL4 A

0

200

400

600

800

1000

FL2-

H:

FL2-

Hei

ght

0 200 400 600 800 1000FL4-A: FL4 A

0

200

400

600

800

1000

FL1

-H:

FL1

-Hei

ght

0 200 400 600 800 1000FL4-A: FL4 A

0

200

400

600

800

1000

FL1-

H: F

L1-H

eigh

t

Control cells

Camptothecin treated

A second parameter reinforced your observations

Page 30: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

FlowJo Allows Line Graphs Over DNA Profiles

Cyclin E

Cyclin A

A second parameter always reinforced your observations

Page 31: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• We used a panel of 3 paired cell lines:sensitive and resistant to identify activity

• It takes several comparisons to efficientlyconfirm at the cellular level effects ofknown activities from a biochemical assay

Results on BMS-250749

Page 32: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Arrest Leads into Apoptosis

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

Page 33: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Apoptosis

An active metabolic processdevised to dismiss stressed cells

unable to cope with the insult

An active act of disappearance

Page 34: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Morphology of Apoptosis

Control Apoptotic

Page 35: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Apoptosis Pictures

Apoptosis a disappearing population

Page 36: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Evaluation Methods

• Annexin V• TdT Tunel• p85PARP• Caspase 3• Many other caspases• Other approaches- The Sub G1 fraction

Best When Linked to DNA profiles

Page 37: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Tunel Assay

Flow Josoftware

0 200 400 600 800 1000FL2-A: DNA-PI

100

101

102

103

104

FL1-H

: dU

TP

-F

ITC

single cells

apoptosis

0 200 400 600 800 1000FL2-A: DNA-PI

100

101

102

103

104

FL1-H

: dU

TP

-F

ITC

single cells

apoptosis

0 200 400 600 800 1000FL2-A: DNA-PI

100

101

102

103

104

FL1-H

: dU

TP

-F

ITC

single cells

apoptosis

0 200 400 600 800 1000FL2-A: DNA-PI

100

101

102

103

104F

L1-H

: dU

TP

-FIT

C

single cells

apoptosis

Dot Plot Overlays

Provides Specificity of Phase

Page 38: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

p85PARP on Drug Effects

0 200 400 600 800 1000FL2-A: PI-DNA

1

10

100

1000

10000

FL1-

H: P8

5-FIT

C

0 200 400 600 800 1000FL2-A: PI-DNA

1

10

100

1000

10000

FL1-

H: P8

5-FIT

C

Vinblastin 5nM Colchicine 10nM

Flow Josoftware

Localization of populations engaged in apoptosis

Page 39: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Apoptosis by Sub-G1, an increasingly growing population

0

200

400

600

800

1000FL2-A: DNA-PI Control

Low dose

High dose

**

*

*

The Sub-G1 Fraction

Page 40: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

When Proliferation, Arrestand Apoptosis Meet

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

A2780/DDP-R

DRUG-CELL CYCLE PROFILES AFTER 24HRS EXPOSURE

A2780/DDP-S

Taxol

Taxotere

Control 2.5 5.0 10 20 40 80 160 320nM Control 2.5 5.0 10 20 40 80 160 320nM

Page 41: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

The Story of BMS-214662

– BMS-214662 is a farnesyl transferase inhibitor withhigh apoptosis induction capabilities.

– Targets on the farnesyl transferase cascade are notexpected to produce any apoptosis in short periods oftime but this compound did it

– An assay needed to be devised to stain forproliferation and apoptosis simultaneously to directlyanswer this question

-Raventos-Suarez,C., Class. K. and Lee F. 2002 The pro-apoptotic FT-inhibitor BMS-214662 selectively targets non-proliferating tumor cells. Demonstration by a new flow cytometric method. ISAC XXI International Congress on AnalyticalCytology .May 2002 San Diego, California. Cytometry supp11: p72

Page 42: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Building An Assay

• Proliferation by BrdU Uptake andevaluation by Dnase treatment: modify theBrdU Flow Kit from BD cat#552598”

• Cell cycle profiles by DNA 7AAD stain• Apoptosis by p85 PARP “use the Anti-PARP p85 fragment Ab from

Promega” cat#G734A”

Page 43: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cisplatin 500nM BMS-214662 9uM

Proliferation and Apoptosis

P

A P+A A P+A

P

Red = non proliferatingBlue = proliferatingGreen = apoptotic non proliferatingP+A = proliferating cells engaged in apoptosis

Control

A P+A

P

Mechanism of Action of BMS-214662

Page 44: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Take Home Messages

• Cell Cycle Profiles are the best handle inaddressing cell behavior, capacity to respond toan stimulus and possible engagement inapoptosis

• Careful preparation of cells is essential

• Multiparameter analysis linked to cell cycleprofiles provide a more complete picture ofcellular activities

Page 45: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Back up data

Page 46: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Profile of CellsGetting to see the numbers

When algorithms don’t seem to fit you can force constrains

FlowJo Software

Page 47: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Cell Cycle Profile of CellsA cell specific signature

Why are times at logarithmic rate of growth taken as optimal?

0200

400600

8001000FL2-A: PI

HCT116

HCT116(VP35)

HCT116(VM46)

A2780/DDP-R

A2780/Tax

A2780/DDP-S

Panel of cell lines growing at logarithmic growth ratesFlowJo Software

Page 48: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

P388 (24h) P388 (48h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

P388/Topo I (48h)P388/Topo I (24h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

HCT116/TopoII (24h) HCT116/TopoII (48h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

HCT116 (48h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

HCT116 (24h)

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

A2780mutp53 (24h) A2780mutp53 (48h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

Control 0.1x 1x 5x 10x 20xIC50 Control 0.1x 1x 5x 10x 20xIC50

A2780mutp53 (24h) A2780mutp53 (48h)

Camptothecin IC50= 10nM

BMS-250749 IC50=3nM

Etoposide IC50= 1.2uM

Results on BMS-250749 Six cell lines two time points plus two control drugs

It takes a panel of comparisons to address population distribution effectsShown are Cells in 3 pairs:sensitive/resistant (TopoII, TopoI and p53)

Page 49: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

• Proliferation activities require more than DNAmeasurements to account for disturbances– BrdU assay

• will identify the S phase and determine doubling times.– Mitotic markers:

• will allow discrimination of G2 and S phases– Cyclins:

• will determine how far into a cell cycle phase cells have beenable to go before stop growing

– Specific altered functions by induced by resistance ormutation mechanisms

Proliferation What and WhenBeyond DNA quantitative analysis

Page 50: Carmen Raventos-Suarez Ph.D. Bristol-Myers Squibb...Carmen Raventos-Suarez Ph.D. Carmen.raventossuarez@bms.com (609-252-6492) Bristol-Myers Squibb A2780/DDP-R DRUG-CELL CYCLE PROFILES

Control Camptothecin Etoposide TAS-103

Control Camptothecin Etoposide TAS-103

More on Mechanism of Action Specificity on Topo II

Long, B.H., Fairchild, C.R., Raventos-Suarez,C., Cornell, L., and Menendez, A.T. Cytotoxic mechanism of TAS-103 is related to topoisomerase II mediated DNA cleavage. 91st Annual meeting of the AACR. San Francisco, April 1-5, 2000.

A Camptothecin ResistantCell line

A Camptothecin SensitiveCell line

Cell Questsoftware